|
Outcomes
|
Aspirin group (n = 21)
|
Non-aspirin group (n = 42)
|
P value
|
|---|
|
Intraoperative blood loss (ml)
|
257.1 ± 119.7
|
296.4 ± 280.8
|
0.540
|
|
Postoperative hemorrhagic events
|
4 (19.0)
|
7 (16.7)
|
> 0.999
|
|
Postoperative cerebral infarction
|
6 (28.6)
|
13 (31.0)
|
0.846
|
|
Postoperative hospital stay (days)
|
14.0 ± 5.4
|
14.5 ± 5.6
|
0.715
|
|
Functional outcome
| | |
0.332
|
|
mRS < 3
|
13 (61.9)
|
31 (73.8)
| |
|
mRS ≥ 3
|
8 (38.1)
|
11 (26.2)
| |
- Categorical variables are presented as number (%), and continuous variables are presented as mean ± standard deviation
